Description: Panelists: [1] provide an overview of embedded value [EV] and appropriate assumptions, and a comparison with fair value [FV], [2] discuss the various stages of management usage of EV, and [3] review a company's recent actual use of EV across products and for the purpose of determining optimal product mix. From the 2002 Record of Society of Actuaries, Volume 28, No. 3. Session 91PD of the Boston Annual Meeting.

Description: From a panel discussion session at the 2002 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, September 19–20, 2002 Panelists discuss the embedded value process, including discount rate, uses for embedded value reporting and implementation issues. Also included a discussion of fair value accounting methodology.

Description: This presentation is a panel discussion, session number 35PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists discuss integrating the risk management function within an enterprise, where the concept involves evaluating, monitoring, controlling, and mitigating risks across the entire insurance company. Topics include quantification of risk exposures, including insurable and financial risk, nonfinancial or operational risk, and modeling risk on a company-wide basis. They discuss how a company might go about setting up a risk management process and what companies are really looking to accomplish. They also discuss the Society of Actuaries goal to make risk management a regular part of actuarial practice through development and improvement of educational materials for actuaries, and through the advancement of the actuarial profession in risk management. Discussion from participants is included.

Description: The panel at this session of the SOA 2001 Annual Meeting discusses the basics of embedded value [EV], how EV can be used to measure an insurance company's results, and current best practices.

Description: This presentation is an open forum, session number 12OF, from the 2000 Valuation Actuary Symposium, held September 14-15 in Washington, DC. The National Association of Insurance Commissioners [NAIC] has proposed a requirement that certain products have risk-based capital [RBC] C-3 determined as the greater of a calculation based on fixed factors, and results of a formalized cash-flow test. The panelists provide a summary of the requirements of C-3 testing, followed by an open discussion regarding implementation issues and other questions.

Description: This presentation is an open forum, session number 8OF, from the 1999 Valuation Actuary Symposium, held September 23-24 in Los Angeles. The panelists explore risk quantification from multiple perspectives, including: value-at-risk techniques and their application in the financial services industry, internal risk-based surplus formulas, and an NAIC Risk-Based Capital [RBC] Update. They discuss the application of existing and emerging risk evaluation techniques to one’s company or client circumstances. Discussion from participants is included.

Description: This presentation is from session number 43, presented at the 1999 Valuation Actuary Symposium, held September 23-24 in Los Angeles. Increasingly, many insurance companies are enhancing the regulatory cash-flow testing for quantitative analysis of their operations. Enhancements include adding new business, extension of the New York 7 scenarios, and other ways of getting value in addition to compliance. Panelists discuss how widespread the practice of leveraging cash-flow testing is to create a strategic, quantitative tool to support management decision making.

Description: Full version of Risks and Rewards Newsletter, August 1999, Issue No. 33.

Description: From a session at the Spring regional meeting of the Society of Actuaries held in Atlanta, Georgia, May 24-25, 1999 Panelists discussed a comprehensive risk management approach to quantify the risk exposure from various sources.

Description: This session at the 1998 Valuation Actuary Symposium looks at how companies can use the cash-flow testing structure for additional analysis and be more useful to the managment of the company. The concept of transfer pricing within a life company is explained.